Samsara BioCapital, LLC

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$729M
Signature - Title
Miran Ahmad - Chief Financial Officer
Location
Palo Alto, CA
Summary
This page shows a list of all the recent 13F filings made by Samsara BioCapital, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Samsara BioCapital, LLC reported 43 stock holdings with total value $729M as of Q4 2024. Top holdings included SRRK, CRGX, SEPN, MLYS, and NGNE.
Holdings Value